{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:32:33Z","timestamp":1792531953690,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"am","delay-in-days":631,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018810","name":"OTC Self-Medication Promotion Foundation","doi-asserted-by":"publisher","award":["28-1-28"],"award-info":[{"award-number":["28-1-28"]}],"id":[{"id":"10.13039\/100018810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003268","name":"Toa Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K0237504"],"award-info":[{"award-number":["24K0237504"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpba.2024.116432","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:17:35Z","timestamp":1724347055000},"page":"116432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Validated UPLC-MS\/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samples"],"prefix":"10.1016","volume":"251","author":[{"given":"Hina","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Furugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Umazume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116432_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","article-title":"Lancet breastfeeding series group, breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect","volume":"387","author":"Victora","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2024.116432_bib2","doi-asserted-by":"crossref","first-page":"690.e1","DOI":"10.1016\/j.ajog.2014.06.013","article-title":"Trends in pregnancy labeling and data quality for US-approved pharmaceuticals","volume":"211","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jpba.2024.116432_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cpt.377","article-title":"Modeling drug passage into human milk","volume":"100","author":"Anderson","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2024.116432_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10865-018-9950-7","article-title":"Poor sleep quality increases symptoms of depression and anxiety in postpartum women","volume":"41","author":"Okun","year":"2018","journal-title":"J. Behav. Med."},{"key":"10.1016\/j.jpba.2024.116432_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","article-title":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis","volume":"269","author":"Bais","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpba.2024.116432_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpba.2019.02.011","article-title":"Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: application to evaluation of alprazolam transfer into breastmilk","volume":"168","author":"Furugen","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116432_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/bfm.2020.0259","article-title":"Benzodiazepine concentrations in the breast milk and plasma of nursing mothers: estimation of relative infant dose","volume":"16","author":"Nishimura","year":"2021","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.jpba.2024.116432_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2024.116432_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13902","article-title":"The orexin story and orexin receptor antagonists for the treatment of insomnia","volume":"32","author":"Muehlan","year":"2023","journal-title":"J. Sleep. Res."},{"key":"10.1016\/j.jpba.2024.116432_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","article-title":"Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: A novel therapeutic drug for sleep disorders","volume":"15","author":"Miyamoto","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jpba.2024.116432_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0091270005283461","article-title":"Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia","volume":"46","author":"Karim","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116432_bib12","unstructured":"Food and Drug Administration, HIGHLIGHTS OF PRESCRIBING INFORMATION BELSOMRA\u00ae (suvorexant) tablets, for oral use Initial U.S. Approval: 2014, Revised: 7\/2018 \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204569s005lbl.pdf\u3009, 2018 (accessed 21 May 2024)."},{"key":"10.1016\/j.jpba.2024.116432_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpba.2024.116432_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113359","article-title":"Establishment of a simultaneous assay for lemborexant, a novel dual orexin receptor antagonist, and its three metabolites, and its application to a clinical protein binding study","volume":"187","author":"Mano","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116432_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/cpdd.817","article-title":"Pharmacokinetics, pharmacodynamics, and safety of the dual orexin receptor antagonist lemborexant: findings from single-dose and multiple-ascending-dose phase 1 studies in healthy adults","volume":"10","author":"Landry","year":"2021","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"10.1016\/j.jpba.2024.116432_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda","year":"2023","journal-title":"Bmc. Psychiatry"},{"key":"10.1016\/j.jpba.2024.116432_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/bfm.2021.0321","article-title":"Presence of hypnotics in the cord blood and breast milk, with no adverse effects in the infant: a case report","volume":"17","author":"Saito","year":"2022","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.jpba.2024.116432_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/bcp.15880","article-title":"Lemborexant levels in breast milk after single doses in healthy, lactating women","volume":"90","author":"Rawal","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116432_bib19","article-title":"Lemborexant levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: a case report","volume":"2","author":"Saito","year":"2023","journal-title":"Psychiatry Clin. Neurosci. Rep."},{"key":"10.1016\/j.jpba.2024.116432_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11419-013-0195-4","article-title":"High-throughput analysis of ramelteon, agomelatine, and melatonin in human plasma by ultra-performance liquid chromatography\u2013tandem mass spectrometry","volume":"32","author":"Ogawa","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2024.116432_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4510","article-title":"LC-MS\/MS method for simultaneous determination of ramelteon and its metabolite M-II in human plasma: application to a clinical pharmacokinetic study in healthy Chinese volunteers","volume":"33","author":"Zhu","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2024.116432_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jat\/bkaa109","article-title":"Novel and nonroutine benzodiazepines and suvorexant by LC-MS-MS","volume":"45","author":"Garcia","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116432_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122265","article-title":"Drug-mediated ion suppression and mitigation of interferences using liquid chromatography-quadrupole\/time of flight mass spectrometry (LC-Q\/TOF-MS) and liquid chromatography tandem mass spectrometry (LC-MS\/MS)","volume":"1152","author":"Skillman","year":"2020","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116432_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jchromb.2015.07.056","article-title":"Determination of suvorexant in human plasma using 96-well liquid-liquid extraction and HPLC with tandem mass spectrometric detection","volume":"1002","author":"Breidinger","year":"2015","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116432_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/toxics11020109","article-title":"UPLC-MS\/MS based identification and quantification of a novel dual orexin receptor antagonist in plasma samples by validated SWGTOX guidelines","volume":"11","author":"Iqbal","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.jpba.2024.116432_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","article-title":"Human milk composition: nutrients and bioactive factors","volume":"60","author":"Ballard","year":"2013","journal-title":"Pediatr. Clin. North. Am."},{"key":"10.1016\/j.jpba.2024.116432_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MPG.0000000000000818","article-title":"Lipid quality in infant nutrition: Current knowledge and future opportunities","volume":"61","author":"Delplanque","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jpba.2024.116432_bib28","doi-asserted-by":"crossref","first-page":"104-","DOI":"10.1016\/j.talanta.2013.03.048","article-title":"Ion suppression; a critical review on causes, evaluation, prevention and applications","volume":"115","author":"Furey","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116432_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40780-023-00295-w","article-title":"Simple and validated method to quantify lacosamide in human breast milk and plasma using UPLC\/MS\/MS and its application to estimate drug transfer into breast milk","volume":"9","author":"Furugen","year":"2023","journal-title":"J. Pharm. Health Care. Sci."},{"key":"10.1016\/j.jpba.2024.116432_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.chroma.2016.03.076","article-title":"Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry","volume":"1446","author":"Swortwood","year":"2016","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2024.116432_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00216-019-01582-y","article-title":"Critical assessment of two sample treatment methods for multiresidue determination of veterinary drugs in milk by UHPLC-MS\/MS","volume":"411","author":"Castilla-Fern\u00e1ndez","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116432_bib32","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s11095-013-1085-5","article-title":"Contribution of protein binding, lipid partitioning, and asymmetrical transport to drug transfer into milk in mouse versus human","volume":"30","author":"Ito","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2024.116432_bib33","unstructured":"Food and Drug Administration, Highlights of prescribing information dayvigotm (lemborexant) tablets, for oral use Initial U.S. Approval: [pending controlled substance scheduling], Revised: 12\/2019, \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212028s000lbl.pdf\u3009, 2019(accessed 6 June 2024)."},{"key":"10.1016\/j.jpba.2024.116432_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.2455","article-title":"Transfer of the dual orexin receptor antagonist daridorexant into breast milk of healthy lactating women","author":"Kaufmann","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116432_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.62641\/aep.v52i2.1659","article-title":"Orexinergic receptor antagonists as a new therapeutic target to overcome limitations of current pharmacological treatment of insomnia disorder","volume":"52","author":"\u00c1lamo","year":"2024","journal-title":"Actas Esp. Psiquiatr."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:32:59Z","timestamp":1778513579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S0731708524004722"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116432","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated UPLC-MS\/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116432"}}